Look for:

Our offer for

Research Detail

2023/03/10 / Erste Group Research

Continued upside in tourism sector in 2023

The consensus forecast for global corporate sales growth in 2023 is +1.3% (y/y). Profits should rise +4.5% (y/y) this year. Sales and profit growth will only increase more strongly next year. Profit growth of +9.2% (y/y) is then forecast for 2024.

The expected global dividend yield in 2023e is 2.3%. It is significantly below the level of the increased yields on US government bonds. This limits the relative attractiveness of equities. We expect the global equity market index to move sideways in March.

Anheuser Busch Inbev: High growth in Central and South America, operating margin well above sector average

Booking Holdings: Sales significantly exceed pre-Covid level, market shares in the USA increased
Charles Schwab: Revenue stagnation in 2023e

PDF Download Download PDF (13.4MB)

General information

AuthorErste Group Research
Date2023/03/10
Languageen
Product nameRecommendation List
Topic in focusEquities
Economy in focusEurozone, Germany, United States
Currency in focusEuro, US Dollar
Sector in focusAutomobiles & Parts, Banks, Basic Resources, Chemicals, Construction & Material, Financial Services, Food & Beverage, Health Care, Industrial Goods & Services, Insurance, Media, Oil & Gas, Personal & Household Goods, Retail, Technology, Telecommunications, Travel & Leisure, Utilities
Download

Related financial instruments

Page 5 of 6
Name  ISIN# Erste Group products
SanofiFR00001205780
SAPDE00071646004
Schneider Electric FR00001219720
ServiceNowUS81762P10210
ShellGB00B03MLX290
SiemensDE00072361010
Southern CoUS84258710710
StarbucksUS85524410940
T-Mobile USUS87259010400
Taiwan SemiconductorTW00023300080
TencentKYG8757216340
Tesla US88160R10140
Thermo Fisher ScientificUS88355610230
Tokyo ElectronJP35714000050
TotalEnergiesFR00001202710
Toyota MotorJP36334000010
UBSCH02447675850
UniCreditIT00052393600
UnileverGB00B10RZP780
UnitedHealth GroupUS91324P10210
ValeBRVALEACNOR00
VerizonUS92343V10440
Vertex Pharmaceuticals US92532F10030
Vestas Wind SystemsDK00102686060
Vinci FR00001254860



Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer